The team, led collaboratively by scientists from St. Jude’s Department of Pathology and Department of Structural Biology, focused on the fundamental biological alterations caused by UBTF tandem duplications. Their inquiry revealed that these duplications instill an aberrant nuclear export signal within the UBTF protein. To unravel this, a comprehensive approach combining genomic, proteomic, structural, and functional analyses was employed. This multidisciplinary investigation demonstrated that UBTF-TD does not behave like its normal counterpart but instead gains an unusual interaction with Exportin-1 (XPO1), a key nuclear transport protein traditionally responsible for shuttling molecules out of the nucleus.

Historically, Exportin-1 functions by recognizing and binding nuclear export signals, facilitating the movement of proteins and RNA from the nucleus to the cytoplasm. However, in the case of UBTF-TD, the duplicated segment creates a “rogue” nuclear export signal that hijacks Exportin-1’s trafficking machinery in an unexpected way. Instead of exporting UBTF-TD out of the nucleus, Exportin-1 is co-opted to position the mutated UBTF protein directly at specific genetic loci. These loci correspond to genes whose dysregulation drives leukemogenesis, underpinning the aggressive clinical nature of UBTF-TD AML.

By uncovering this novel protein-protein interaction, the research sheds light on a previously unknown oncogenic mechanism: rather than merely functioning as a passive transcription factor, UBTF-TD exploits nuclear export machinery to remodel gene expression landscapes in favor of leukemic progression. This insight reframes UBTF-TD AML as a disease where aberrant nuclear transport signals are paramount to the cancer’s molecular pathology, providing a fresh angle for therapeutic intervention.

Notably, the team demonstrated that this abnormal association between UBTF-TD and Exportin-1 could be effectively disrupted with selective Exportin-1 inhibitors. These small molecules, already under investigation for other malignancies exhibiting reliance on export pathways, showed promising preclinical efficacy in patient-derived models of UBTF-TD AML. Treatment with Exportin-1 inhibitors significantly reduced tumor burden, confirming the therapeutic potential of targeting this interaction in clinical contexts.

The implications of these findings transcend just UBTF-TD AML. Since nuclear export dysregulation is a feature in various cancers, this work exemplifies how intricate structural biology insights can reveal novel oncogenic mechanisms and corresponding druggable dependencies. Moreover, the collaboration between structural biologists and translational cancer researchers underscores the importance of an integrated scientific approach in tackling complex cancers.

From a mechanistic perspective, the study elucidated that the tandem duplications within UBTF engendered an exposed nuclear export signal due to disruption of a normally folded protein region. Advanced structural analyses employing purified protein complexes confirmed that these duplications destabilize a specific UBTF domain, unveiling an otherwise hidden amino acid sequence that serves as a high-affinity binding site for Exportin-1. This precise structural revelation provided the molecular rationale for the aberrant nuclear transport behavior observed in UBTF-TD AML.

Furthermore, the research team pinpointed the heterogeneous nature of these tandem duplications, noting that while the exact sequence variability exists among patients, they converge functionally by creating similar nuclear export motifs. This explains why multiple distinct tandem duplication events can lead to an identical pathogenic phenotype, an insight crucial for understanding disease heterogeneity and guiding therapeutic development.

The researchers also highlighted the interplay of UBTF-TD with genes that become aberrantly activated, illustrating how this mechanism amplifies oncogene expression driving leukemogenesis. By co-opting Exportin-1 to localize to these pathogenic loci, UBTF-TD enforces a transcriptional program favorable to leukemia maintenance and progression. Interrupting this cycle with Exportin-1 inhibition potentially offers a means to reverse malignant gene expression profiles.

Beyond therapeutic applications, this discovery opens avenues for deeper inquiry into nuclear export dynamics in cancer biology. Understanding how altered nuclear export signals modulate chromatin architecture and gene regulatory networks could reveal further vulnerabilities. Continued dissection of the UBTF-TD/Exportin-1 complex, including other associated biomolecules, promises to uncover even more specific therapeutic targets with improved efficacy and selectivity.

St. Jude’s pioneering investigations into UBTF-TD AML exemplify the rapid translation of molecular insights into actionable clinical strategies. Previously, the lab’s work illuminated Menin inhibitors as a therapeutic option targeting UBTF-TD driven oncogene overexpression. This current study, by identifying a second independent mechanism-centered target, showcases the potential of multi-pronged approaches tailored to the unique molecular signatures of pediatric leukemias.

This research also underscores the critical nature of studying high-risk pediatric cancer subtypes with rigorous experimental methodologies spanning genomics, structural biology, and preclinical modeling. The success of these studies relies heavily on collaborative networks within research institutions that pool expertise to accelerate translational discoveries, exemplified by the partnership between Clincial and Structural Biology labs at St. Jude.

With acute myeloid leukemia in children remaining a deadly disease for many, the revelation of the UBTF-TD and Exportin-1 interaction as a therapeutic dependency marks a hopeful step forward. The development of drugs targeting this axis could, in time, improve outcomes for patients facing this devastating diagnosis. Ultimately, this work invigorates the broader cancer research field to consider nuclear export pathways as critical nodes in oncogenic networks ripe for targeted intervention.

The broader impact of this study will likely prompt renewed focus on the structural determinants of nuclear transport signals altered in cancer, sparking novel avenues for drug discovery. As Exportin-1 inhibitors advance in clinical development, their potential repurposing for treating aggressive leukemias such as UBTF-TD AML could transform pediatric oncology paradigms. Thus, St. Jude’s research not only enriches our molecular understanding but also kindles optimism for targeted therapies that change lives.

Subject of Research: Cells
Article Title: Tandem duplications in UBTF create XPO1-dependent nuclear export signals that reveal a leukemic therapeutic dependency
News Publication Date: 3-Nov-2025
Image Credits: Courtesy of St. Jude Children’s Research Hospital
Keywords: Leukemia

This research is particularly significant given the essential role chromatin remodeling plays in cellular function. The chromatin structure comprises DNA tightly wrapped around proteins called histones, forming nucleosomes that package the genetic material within the nucleus. These nucleosomes can slide along the DNA strand, a process that regulates gene accessibility and, consequently, gene expression. However, the precise mechanics of how remodeling occurs have remained elusive, until now.

To tackle this challenge, Halic and his team employed cryo-electron microscopy (cryo-EM), a sophisticated imaging technique that allows for the observation of biomolecules in near-native states at high resolution. This method enabled them to capture SNF2H in real-time as it interacted with nucleosomes in the presence of ATP, the energy currency of the cell. Unlike previous studies that focused on static snapshots of the protein in various states, this innovative approach provided insights into the continuous motions of the remodeling enzyme as it manipulated the DNA structure.

The analysis of data yielded 13 distinct states of the SNF2H-nucleosome complex, each corresponding to different moments during the nucleosome sliding process. By categorizing these structures into five groups based on their respective functional states, the researchers were able to piece together the dynamic choreography of the remodeling process. This comprehensive mapping sheds light on the intricate relationship between structural changes in chromatin and the regulation of gene accessibility.

An intriguing aspect of this research involved the systematic introduction of specific mutations and crosslinks—artificial restraints designed to stabilize certain conformations of the protein. This experimental strategy allowed the researchers to verify the significance of particular movements in the SNF2H function. Through this meticulous approach, the team was able to resolve several conflicting observations in the existing literature, paving the way for a more cohesive understanding of nucleosome sliding and its implications for gene regulation.

Halic’s commentary highlights the relevance of this work: “Nucleosomes carry all the genetic information inside the nucleus of the eukaryotic cell. Chromatin remodelers help the cell access and propagate that information.” This underscores the essential nature of understanding the mechanics of chromatin remodeling. By deciphering how these enzymes work, scientists can better appreciate the fundamental biological processes that dictate gene expression, which are often disrupted in various diseases, including cancer.

The significance of SNF2H in developmental processes cannot be overstated. Disruptions in the activity of this enzyme have been implicated in developmental disorders, making the understanding of its function crucial not only for basic biology but also for medical research. The insights gained from this study could inform therapeutic strategies aimed at restoring normal chromatin dynamics in diseased states.

The research was backed by substantial funding from the National Institutes of Health and the American Lebanese Syrian Associated Charities (ALSAC), reflecting the importance and potential impact of this investigation. Collaborative efforts like this one highlight the evolving intersection of structural biology and medicine, emphasizing a collective pursuit to elucidate the cellular mechanisms that govern life.

In summary, this pioneering work unveils a nuanced understanding of the dynamics involved in chromatin remodeling through the actions of SNF2H, illustrating the dance of molecular interactions that govern gene regulation. As the field progresses, such studies will undoubtedly lay the groundwork for future investigations into chromatin dynamics, informing how we approach genetic expression in health and disease.

Understanding the detailed mechanics of chromatin remodeling not only enhances our foundational knowledge but also opens avenues for targeted medical interventions. As researchers continue to adopt innovative imaging techniques and experimental approaches, the path to unraveling the complexities of gene regulation becomes increasingly clearer, heralding a new era in molecular biology research.

Through a combination of advanced technology and thoughtful experimental designs, the study of SNF2H stands as a testament to the progress we can achieve in understanding the intricate workings of the cell. This research not only broadens our understanding of chromatin dynamics but also beckons a stronger focus on how these molecular processes can be harnessed to treat diseases that arise from dysregulated gene expression.

By continuing to explore the multifaceted interactions within the nucleus, scientists are poised to illuminate the pathways that connect genetic information with cellular function and organismal development. The insights drawn from this research will undoubtedly inspire subsequent studies aimed at further unraveling the mysteries of chromatin remodeling, paving the way for innovative therapeutic strategies to combat genetic and epigenetic diseases.

As we delve deeper into the structural intricacies of chromatin remodelers like SNF2H, we are reminded of the elegant complexity of life at the molecular level. This study not only contributes to our understanding of chromatin dynamics but also serves as a catalyst for future research endeavors aimed at unlocking the potential of gene regulation.

Subject of Research: Chromatin remodeling and gene regulation
Article Title: Comprehensive Structural Study of the Chromatin Remodeler SNF2H
News Publication Date: April 3, 2025
Web References: Cell Research Publication
References: National Institutes of Health grants 1R01GM135599 and 1R01GM141694; American Lebanese Syrian Associated Charities (ALSAC).
Image Credits: St. Jude Children’s Research Hospital

Keywords: Chromatin remodeling, SNF2H, nucleosome sliding, gene regulation, structural biology, cryo-electron microscopy, ATP hydrolysis, protein interactions, disease implications, developmental disorders.